Mi Ra Park

Title: Mi Ra Park: Innovator in Antibody Development

Introduction

Mi Ra Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that have therapeutic applications. His work focuses on innovative solutions for various medical conditions.

Latest Patents

Mi Ra Park holds a patent for an "Anti-c-Met antibody having HGF activity and use thereof." This patent discloses a human antibody that comprises a human complementarity-determining region (CDR) specifically binding to c-Met. The invention includes a polynucleotide encoding the human antibody, an expression vector, and a transformant transformed with the expression vector. The method of producing the human antibody B7 involves culturing the transformant. The antibody can be utilized in wound healing compositions and cell regeneration compositions. It serves as an HGF mimic, which can be beneficial in treating various diseases, including neuronal infarction, progressive nephropathy, liver cirrhosis, lung fibrosis, kidney injury, liver injury, lung injury, and ulcerative wounds.

Career Highlights

Throughout his career, Mi Ra Park has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and Y-Biologics Inc. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Mi Ra Park has collaborated with notable colleagues, including Young Woo Park and Ki Won Jo. These partnerships have fostered innovation and development in his research endeavors.

Conclusion

Mi Ra Park is a distinguished inventor whose work in antibody development has the potential to impact various medical treatments significantly. His innovative approaches and collaborations continue to advance the field of biotechnology.